Grading and Tissue-Specific Diagnosis

  • Filip M. VanhoenackerEmail author
  • Arthur M. De Schepper


This chapter provides an overview of the value of imaging in grading and tissue-specific diagnosis of soft tissue tumors (STT). While tissue-specific diagnosis implies pathological typing, grading implies differentiation between benign and malignant tumors and definition of malignancy grade. Some (mostly benign) lesions are characteristic on imaging. On the other hand, prediction of tissue-specific diagnosis of malignant lesions based on imaging is far less accurate and often impossible. The best results in grading and tissue-specific diagnosis are obtained by a combination of multiple nonimaging and imaging parameters. Compared to other imaging methods, MRI is the most useful imaging technique. Indeterminate lesions on imaging should be referred for further biopsy.


Soft Tissue Tumor Desmoid Tumor Glomus Tumor Clear Cell Sarcoma Myxoid Liposarcoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



The current revision of this chapter is gratefully dedicated to the memory of Professor Arthur De Schepper (November 30, 1937–October 4, 2013).


  1. 1.
    Berquist TH, Ehman RL, King BF, Hodgman CG, Ilstrup DM (1990) Value of MR imaging in differentiating benign from malignant soft-tissue masses: study of 95 lesions. AJR Am J Roentgenol 155:1251–1255. doi: 10.2214/ajr.155.6.2122675 CrossRefPubMedGoogle Scholar
  2. 2.
    De Beuckeleer LH, De Schepper AM, Vandevenne JE, Bloem JL, Davies AM, Oudkerk M, Hauben E, Van Marck E, Somville J, Vanel D, Steinbach LS, Guinebretière JM, Hogendoorn PC, Mooi WJ, Verstraete K, Zaloudek C, Jones H (2000) MR imaging of clear cell sarcoma (malignant melanoma of the soft parts): a multicenter correlative MRI-pathology study of 21 cases and literature review. Skeletal Radiol 29:187–195CrossRefPubMedGoogle Scholar
  3. 3.
    Bongartz G, Vestring T, Peters PE (1992) Magnetic resonance tomography of soft tissue tumors. Radiologe 32:584–590PubMedGoogle Scholar
  4. 4.
    Buchbender C, Heusner TA, Lauenstein TC, Bockisch A, Antoch G (2012) Oncologic PET/MRI, part 2: bone tumors, soft-tissue tumors, melanoma, and lymphoma. J Nucl Med 53:1244–1252. doi: 10.2967/jnumed.112.109306 CrossRefPubMedGoogle Scholar
  5. 5.
    Chen C-K, Wu H-T, Chiou H-J, Wei C-J, Yen C-H, Chang C-Y, Chen W-M (2009) Differentiating benign and malignant soft tissue masses by magnetic resonance imaging: role of tissue component analysis. J Chin Med Assoc 72:194–201. doi: 10.1016/S1726-4901(09)70053-X CrossRefPubMedGoogle Scholar
  6. 6.
    Chung WJ, Chung HW, Shin MJ, Lee SH, Lee MH, Lee JS, Kim M-J, Lee WK (2012) MRI to differentiate benign from malignant soft-tissue tumours of the extremities: a simplified systematic imaging approach using depth, size and heterogeneity of signal intensity. Br J Radiol 85:e831–e836. doi: 10.1259/bjr/27487871 CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Crim JR, Seeger LL, Yao L, Chandnani V, Eckardt JJ (1992) Diagnosis of soft-tissue masses with MR imaging: can benign masses be differentiated from malignant ones? Radiology 185:581–586. doi: 10.1148/radiology.185.2.1410377 CrossRefPubMedGoogle Scholar
  8. 8.
    Fayad LM, Jacobs MA, Wang X, Carrino JA, Bluemke DA (2012) Musculoskeletal tumors: how to use anatomic, functional, and metabolic MR techniques. Radiology 265:340–356. doi: 10.1148/radiol.12111740 CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Fisher SM, Joodi R, Madhuranthakam AJ, Öz OK, Sharma R, Chhabra A (2016) Current utilities of imaging in grading musculoskeletal soft tissue sarcomas. Eur J Radiol 85:1336–1344. doi: 10.1016/j.ejrad.2016.05.003 CrossRefPubMedGoogle Scholar
  10. 10.
    Fletcher CDM, Bridge JA, Hogendoorn PCW, Mertens F (eds) (2013) WHO classification of tumours of soft tissue and bone. IARC Press, LyonGoogle Scholar
  11. 11.
    Galant J, Martí-Bonmatí L, Soler R, Saez F, Lafuente J, Bonmatí C, Gonzalez I (1998) Grading of subcutaneous soft tissue tumors by means of their relationship with the superficial fascia on MR imaging. Skeletal Radiol 27:657–663CrossRefPubMedGoogle Scholar
  12. 12.
    Gielen JLMA, De Schepper AM, Vanhoenacker F, Parizel PM, Wang XL, Sciot R, Weyler J (2004) Accuracy of MRI in characterization of soft tissue tumors and tumor-like lesions. A prospective study in 548 patients. Eur Radiol 14:2320–2330. doi: 10.1007/s00330-004-2431-0 CrossRefPubMedGoogle Scholar
  13. 13.
    Hanna SL, Fletcher BD (1995) MR imaging of malignant soft-tissue tumors. Magn Reson Imaging Clin N Am 3:629–650PubMedGoogle Scholar
  14. 14.
    Hermann G, Abdelwahab IF, Miller TT, Klein MJ, Lewis MM (1992) Tumour and tumour-like conditions of the soft tissue: magnetic resonance imaging features differentiating benign from malignant masses. Br J Radiol 65:14–20. doi: 10.1259/0007-1285-65-769-14 CrossRefPubMedGoogle Scholar
  15. 15.
    Jeon JY, Chung HW, Lee MH, Lee SH, Shin MJ (2016) Usefulness of diffusion-weighted MR imaging for differentiating between benign and malignant superficial soft tissue tumours and tumour-like lesions. Br J Radiol 89:20150929. doi: 10.1259/bjr.20150929 CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Kransdorf MJ (1995) Benign soft-tissue tumors in a large referral population: distribution of specific diagnoses by age, sex, and location. AJR Am J Roentgenol 164:395–402. doi: 10.2214/ajr.164.2.7839977 CrossRefPubMedGoogle Scholar
  17. 17.
    Kransdorf MJ (1995) Malignant soft-tissue tumors in a large referral population: distribution of diagnoses by age, sex, and location. AJR Am J Roentgenol 164:129–134. doi: 10.2214/ajr.164.1.7998525 CrossRefPubMedGoogle Scholar
  18. 18.
    Lee S-Y, Jee W-H, Jung J-Y, Park MY, Kim S-K, Jung C-K, Chung Y-G (2016) Differentiation of malignant from benign soft tissue tumours: use of additive qualitative and quantitative diffusion-weighted MR imaging to standard MR imaging at 3.0 T. Eur Radiol 26:743–754. doi: 10.1007/s00330-015-3878-x CrossRefPubMedGoogle Scholar
  19. 19.
    Mirowitz SA, Totty WG, Lee JK (1992) Characterization of musculoskeletal masses using dynamic Gd-DTPA enhanced spin-echo MRI. J Comput Assist Tomogr 16:120–125PubMedGoogle Scholar
  20. 20.
    Moulton JS, Blebea JS, Dunco DM, Braley SE, Bisset GS, Emery KH (1995) MR imaging of soft-tissue masses: diagnostic efficacy and value of distinguishing between benign and malignant lesions. AJR Am J Roentgenol 164:1191–1199. doi: 10.2214/ajr.164.5.7717231 CrossRefPubMedGoogle Scholar
  21. 21.
    Noebauer-Huhmann IM, Weber M-A, Lalam RK, Trattnig S, Bohndorf K, Vanhoenacker F, Tagliafico A, Van Rijswijk C, Vilanova JC, Afonso PD, Breitenseher M, Beggs I, Robinson P, De Jonge MC, Krestan C, Bloem JL (2015) Soft tissue tumors in adults: ESSR-approved guidelines for diagnostic imaging. Semin Musculoskelet Radiol 19:475–482. doi: 10.1055/s-0035-1569251 CrossRefPubMedGoogle Scholar
  22. 22.
    Oliveira AM, Nascimento AG (2001) Grading in soft tissue tumors: principles and problems. Skeletal Radiol 30:543–559. doi: 10.1007/s002560100408 CrossRefPubMedGoogle Scholar
  23. 23.
    van Rijswijk CSP, Geirnaerdt MJA, Hogendoorn PCW, Taminiau AHM, van Coevorden F, Zwinderman AH, Pope TL, Bloem JL (2004) Soft-tissue tumors: value of static and dynamic gadopentetate dimeglumine-enhanced MR imaging in prediction of malignancy. Radiology 233:493–502. doi: 10.1148/radiol.2332031110 CrossRefPubMedGoogle Scholar
  24. 24.
    van Rijswijk CSP, Kunz P, Hogendoorn PCW, Taminiau AHM, Doornbos J, Bloem JL (2002) Diffusion-weighted MRI in the characterization of soft-tissue tumors. J Magn Reson Imaging 15:302–307CrossRefPubMedGoogle Scholar
  25. 25.
    De Schepper AM, Bloem JL (2007) Soft tissue tumors: grading, staging, and tissue-specific diagnosis. Top Magn Reson Imaging 18:431–444. doi: 10.1097/rmr.0b013e3181652220 CrossRefPubMedGoogle Scholar
  26. 26.
    De Schepper AM, Ramon FA, Degryse HR (1992) Magnetic resonance imaging of soft tissue tumors. J Belge Radiol 75:286–296PubMedGoogle Scholar
  27. 27.
    De Schepper AM, Ramon FA, Degryse HR (1992) Statistical analysis of MRI parameters predicting malignancy in 141 soft tissue masses. RöFo Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nukl 156:587–591. doi: 10.1055/s-2008-1032948 CrossRefGoogle Scholar
  28. 28.
    Sen J, Agarwal S, Singh S, Sen R, Goel S (2010) Benign vs malignant soft tissue neoplasms: limitations of magnetic resonance imaging. Indian J Cancer 47:280–286. doi: 10.4103/0019-509X.64725 CrossRefPubMedGoogle Scholar
  29. 29.
    Sundaram M (1999) MR imaging of soft tissue tumors: an overview. Semin Musculoskelet Radiol 3:15–20. doi: 10.1055/s-2008-1080048 CrossRefPubMedGoogle Scholar
  30. 30.
    Sundaram M, McLeod RA (1990) MR imaging of tumor and tumorlike lesions of bone and soft tissue. AJR Am J Roentgenol 155:817–824. doi: 10.2214/ajr.155.4.2119115 CrossRefPubMedGoogle Scholar
  31. 31.
    Sundaram M, Sharafuddin MJ (1995) MR imaging of benign soft-tissue masses. Magn Reson Imaging Clin N Am 3:609–627PubMedGoogle Scholar
  32. 32.
    Tung GA, Davis LM (1993) The role of magnetic resonance imaging in the evaluation of the soft tissue mass. Crit Rev Diagn Imaging 34:239–308PubMedGoogle Scholar
  33. 33.
    van Unnik JA, Coindre JM, Contesso C, Albus-Lutter CE, Schiodt T, Sylvester R, Thomas D, Bramwell V, Mouridsen HT (1993) Grading of soft tissue sarcomas: experience of the EORTC Soft Tissue and Bone Sarcoma Group. Eur J Cancer 29A:2089–2093CrossRefPubMedGoogle Scholar
  34. 34.
    Vandevenne JE, De Schepper AM, De Beuckeleer L, Van Marck E, Aparisi F, Bloem JL, Erkorkmaz Z, Brijs S (1997) New concepts in understanding evolution of desmoid tumors: MR imaging of 30 lesions. Eur Radiol 7:1013–1019. doi: 10.1007/s003300050243 CrossRefPubMedGoogle Scholar
  35. 35.
    Vanhoenacker FM, Van Looveren K, Trap K, Desimpelaere J, Wouters K, Van Dyck P, Parizel PM, De Schepper AM (2012) Grading and characterization of soft tissue tumors on magnetic resonance imaging: the value of an expert second opinion report. Insights Imaging 3:131–138. doi: 10.1007/s13244-012-0151-6 CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Vanhoenacker FM, Verstraete KL (2015) Soft tissue tumors about the shoulder. Semin Musculoskelet Radiol 19:284–299. doi: 10.1055/s-0035-1549322 CrossRefPubMedGoogle Scholar
  37. 37.
    Verstraete KL, De Deene Y, Roels H, Dierick A, Uyttendaele D, Kunnen M (1994) Benign and malignant musculoskeletal lesions: dynamic contrast-enhanced MR imaging--parametric “first-pass” images depict tissue vascularization and perfusion. Radiology 192:835–843. doi: 10.1148/radiology.192.3.8058957 CrossRefPubMedGoogle Scholar
  38. 38.
    Walker EA, Fenton ME, Salesky JS, Murphey MD (2011) Magnetic resonance imaging of benign soft tissue neoplasms in adults. Radiol Clin North Am 49:1197–217. doi: 10.1016/j.rcl.2011.07.007, viCrossRefPubMedGoogle Scholar
  39. 39.
    Walker EA, Salesky JS, Fenton ME, Murphey MD (2011) Magnetic resonance imaging of malignant soft tissue neoplasms in the adult. Radiol Clin North Am 49:1219–34. doi: 10.1016/j.rcl.2011.07.006, viCrossRefPubMedGoogle Scholar
  40. 40.
    Wetzel LH, Levine E (1990) Soft-tissue tumors of the foot: value of MR imaging for specific diagnosis. AJR Am J Roentgenol 155:1025–1030. doi: 10.2214/ajr.155.5.2120930 CrossRefPubMedGoogle Scholar
  41. 41.
    Woertler K (2005) Soft tissue masses in the foot and ankle: characteristics on MR imaging. Semin Musculoskelet Radiol 9:227–242. doi: 10.1055/s-2005-921942 CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Authors and Affiliations

  • Filip M. Vanhoenacker
    • 1
    • 2
    Email author
  • Arthur M. De Schepper
    • 1
    • 2
  1. 1.Department of RadiologyAZ Sint-Maarten, Duffel-MechelenDuffelBelgium
  2. 2.Faculty of Medicine and Health SciencesAntwerp University and University GhentEdegemBelgium

Personalised recommendations